ALTSTATION.IO

Axon Enterprise, Inc. (AXON) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$403.03

Change

+0.85%

Market Cap

$32.02B

Avg Volume

867.5K

Company Overview

Axon Enterprise, Inc. develops technology solutions for public safety, focusing on law enforcement agencies both in the U.S. and internationally. Their offerings fall into two main categories: Software and Sensors, and TASER products. The Software and Sensors segment includes body cameras, in-car cameras, and cloud-based software for video and digital evidence management. The TASER segment is centered around conductive energy devices (CEDs), batteries, accessories, and various training solutions, including virtual reality content. Axon serves a broad customer base, including federal, state, and local law enforcement, emergency services, and commercial enterprises.

Axon holds a strong position in the public safety technology sector, effectively making it a market leader. Their competitive advantage stems from brand recognition, innovation in products, and a comprehensive suite that integrates hardware with software solutions. However, they face competition from companies like Motorola Solutions and ShotSpotter, who also provide critical technology to law enforcement. Market dynamics, such as increasing public scrutiny on policing methods and rising budgets for technology in law enforcement, both support growth and introduce challenges.

Currently, Axon is in a growth phase. Revenues have shown consistent increases, reflected in their Q3 2023 earnings report, where they recorded a 30% year-over-year revenue growth. The company is also expanding its product offerings and recently launched a new AI-driven software feature aimed at improving incident response times. As law enforcement agencies continue to adopt advanced technology, Axon stands to benefit from this trend while navigating regulatory pressures around its product uses.

Key Financials

Market Cap

$32.02B

Revenue

$2.56B

EBITDA

$71.20M

Gross Margin

60.4%

Profit Margin

10.1%

Revenue Growth

30.6%

Total Cash

$2.44B

Total Debt

$2.10B

Free Cash Flow

$248.67M

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

127.54

Forward P/E

53.24

Beta

1.48

52-Week High

$885.92

52-Week Low

$397.08

EPS

$3.16

50-Day Avg

$566.62

200-Day Avg

$682.95

Price/Book

10.50

Technical Analysis

Over the 52-week period, Axon Enterprise, Inc. (AXON) has exhibited a strong downward trend, with a substantial decline of 38.9% from its previous highs. Key resistance is observed at approximately $700, evidenced by multiple peaks in the mid-year range, while support is identified around $400, where the price currently rests. The chart reveals a head-and-shoulders pattern forming between June and December, suggesting a bearish reversal. Recent momentum has been notably weak, particularly in January and February, with accelerating declines leading up to the current price of $403.03. This price is near the lower end of the 52-week range, implying a potential for further downside if support at $400 cannot hold. Overall, the bearish sentiment suggests caution for investors considering entry points or existing positions.

Recent News and Developments

Here are the latest news and developments for Axon Enterprise, Inc

(AXON) stock in the past week:

1. Department of Homeland Security Initiatives Boost Body Camera Demand

The U.S. Department of Homeland Security (DHS) announced plans to immediately equip all officers in Minneapolis with body cameras, a move expected to expand nationwide as funding becomes available. This regulatory development is seen as a significant opportunity for Axon, a leading supplier of body cameras and evidence management tools, potentially driving increased demand for its products and cloud services. William Blair reiterated an “Outperform” rating on Axon following this announcement, aligning with broader analyst sentiment.

2. Axon Reports Mixed Q4 2025 Earnings, Missing EPS Estimates

Axon Enterprise released its fourth-quarter 2025 earnings, reporting an EPS of $1.17, which missed analysts’ consensus estimates of $1.63. However, the company’s revenue for the quarter rose by 30.6% to $710.6 million, surpassing analysts’ expectations of $704.83 million. The earnings report indicated strong revenue growth despite the EPS miss.

Market Sentiment and Analyst Recommendations

Bull Case

Axon is growing revenue at 30.6% while sitting at a 127x P/E multiple that punishes it for missing earnings despite beating revenue. The DHS body camera rollout is real demand tailored to Axon’s core business, not speculative. The company has $2.44B in cash against $2.10B in debt, giving it fortress-level balance sheet flexibility for acquisitions or shareholder returns. Analysts see $815 as fair value on average, implying 102% upside from current levels at $403. The stock collapsed 35% in a week on SaaS valuation concerns, not on Axon-specific fundamentals breaking. If the market reprices software stocks higher or Axon proves it can convert revenue growth into earnings, this becomes a 50-60% move in months.

Bear Case

A P/E of 127 is not a valuation discount waiting to happen, it’s a valuation landmine. Axon missed EPS by 28% while beating revenue by less than 1%, signaling real trouble converting topline growth to bottom-line profit. The stock has collapsed 38.9% from highs and is testing $400 support with a head-and-shoulders pattern suggesting further downside. Momentum is accelerating lower into February, not stabilizing. The SaaS selloff isn’t irrational paranoia, it’s a repricing of perpetual growth assumptions that Axon’s own earnings miss validates. Until Axon demonstrates it can grow revenue AND deliver earnings in line with expectations, the market’s skepticism is justified.

What to Watch

Q1 2026 earnings will be the real test. Investors need to see if Axon can hit EPS guidance while maintaining 30% revenue growth, or if the miss was a one-off. Watch whether the DHS body camera rollout translates to actual bookings in the next quarter’s guidance. If the stock holds above $400 support and closes above $700 resistance, technical momentum flips and could unlock another leg up toward the $815 analyst target. Track Axon’s gross margins and operating leverage on that 30% revenue growth. If margins compress further, growth means nothing. Finally, monitor broader SaaS sentiment and whether the Magnificent 7 rotation eases pressure on software valuations generally.

Analyst Consensus

BUY

Based on 17 analyst opinions

Low Target

$610.00

Mean Target

$815.00

High Target

$925.00

Earnings and Financial Data

Sector

Industrials

Industry

Aerospace & Defense

Employees

4,100

Earnings & Dividends

Next Earnings

Feb 24, 2026

EPS (Trailing)

$3.16

Dividend Yield

None

Payout Ratio

Frequently Asked Questions

Is AXON a good stock to buy?

Yes, analysts recommend AXON as a BUY, with a target price of $815.00. The current price of $403.03 offers significant upside potential.

What is AXON’s price target?

The price target for AXON is $815.00, representing a potential increase of approximately 102% from the current price. This indicates strong future growth expectations.

Does AXON pay a dividend?

No, AXON does not pay a dividend. The company is focused on growth and reinvestment rather than returning capital to shareholders.

What is AXON’s P/E ratio?

AXON’s current P/E ratio stands at 127.54, while the forward P/E is 53.24. These figures suggest that the stock may be overvalued based on current earnings but could still deliver strong future growth.

What has been AXON’s 52-week price range?

AXON’s 52-week price range is between $397.08 and $885.92. This volatility indicates a fluctuating market sentiment around the stock but also highlights the potential for rapid gains.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.